|
Avandia was approved for sale in 1999 for treatment of Type 2 diabetes. It is sold alone as Avandia and in combination with other drugs, including Avandamet and Avandryl.
Cardiologists have noted that alternative treatments with more favorable risk profiles exist, and have questioned why doctors would continue to prescribe Avandia given these risks. Patients taking Avandia are encouraged not to stop taking Avandia without first consulting with their physicians.
Concerns about the safety of Avandia date back to March 2000, when Dr. John Buse, president-elected of the American Diabetes Association and faculty member at the University of North Carolina in Chapel Hill, sent a letter to the FDA and cited "a worrisome trend in cardiovascular deaths and severe adverse events" among patients using Avandia. |
Greg Monforton and Partners has grown to a highly respected products liability law firm with offices conveniently
located throughout Windsor and Essex County, together with affiliate relationships with law firms throughout
Ontario, Canada and the United States.
We are committed to protecting the rights of individuals injured by dangerous pharmaceuticals. The firm never
represents insurance companies or product manufacturers. We only help people.
|
